These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25506899)

  • 1. Pancreatic cancer metastasis: are we being pre-EMTed?
    Das S; Batra SK
    Curr Pharm Des; 2015; 21(10):1249-55. PubMed ID: 25506899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epithelial to mesenchymal transition in pancreatic cancer: A systematic review.
    Beuran M; Negoi I; Paun S; Ion AD; Bleotu C; Negoi RI; Hostiuc S
    Pancreatology; 2015; 15(3):217-25. PubMed ID: 25794655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial-mesenchymal transition in pancreatic cancer: Is it a clinically significant factor?
    Jiang JH; Liu C; Cheng H; Lu Y; Qin Y; Xu YF; Xu J; Long J; Liu L; Ni QX; Yu XJ
    Biochim Biophys Acta; 2015 Jan; 1855(1):43-9. PubMed ID: 25432020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detailed analysis of epithelial-mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma.
    Kohler I; Bronsert P; Timme S; Werner M; Brabletz T; Hopt UT; Schilling O; Bausch D; Keck T; Wellner UF
    J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():78-84. PubMed ID: 25827809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.
    Sannino G; Armbruster N; Bodenhöfer M; Haerle U; Behrens D; Buchholz M; Rothbauer U; Sipos B; Schmees C
    Oncotarget; 2016 Nov; 7(45):73725-73738. PubMed ID: 27713160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial to mesenchymal transition and the generation of stem-like cells in pancreatic cancer.
    Rhim AD
    Pancreatology; 2013; 13(2):114-7. PubMed ID: 23561968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer.
    Yamada S; Fuchs BC; Fujii T; Shimoyama Y; Sugimoto H; Nomoto S; Takeda S; Tanabe KK; Kodera Y; Nakao A
    Surgery; 2013 Nov; 154(5):946-54. PubMed ID: 24075276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microenvironment participates in metastasis of pancreatic cancer.
    Ren B; Cui M; Yang G; Wang H; Feng M; You L; Zhao Y
    Mol Cancer; 2018 Jul; 17(1):108. PubMed ID: 30060755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
    Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer.
    Nomura A; Banerjee S; Chugh R; Dudeja V; Yamamoto M; Vickers SM; Saluja AK
    Oncotarget; 2015 Apr; 6(10):8313-22. PubMed ID: 25829252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of GP73 promotes cell invasion, migration and metastasis by inducing epithelial-mesenchymal transition in pancreatic cancer.
    Song YX; Xu ZC; Li HL; Yang PL; Du JK; Xu J
    Pancreatology; 2018 Oct; 18(7):812-821. PubMed ID: 30217697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging role of LOXL2 in the promotion of pancreas cancer metastasis.
    Park JS; Lee JH; Lee YS; Kim JK; Dong SM; Yoon DS
    Oncotarget; 2016 Jul; 7(27):42539-42552. PubMed ID: 27285767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D receptor signaling and pancreatic cancer cell EMT.
    Li Z; Guo J; Xie K; Zheng S
    Curr Pharm Des; 2015; 21(10):1262-7. PubMed ID: 25506892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GM-CSF Mediates Mesenchymal-Epithelial Cross-talk in Pancreatic Cancer.
    Waghray M; Yalamanchili M; Dziubinski M; Zeinali M; Erkkinen M; Yang H; Schradle KA; Urs S; Pasca Di Magliano M; Welling TH; Palmbos PL; Abel EV; Sahai V; Nagrath S; Wang L; Simeone DM
    Cancer Discov; 2016 Aug; 6(8):886-99. PubMed ID: 27184426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer.
    Zhou P; Li B; Liu F; Zhang M; Wang Q; Liu Y; Yao Y; Li D
    Mol Cancer; 2017 Feb; 16(1):52. PubMed ID: 28245823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epithelial-to-mesenchymal transition induced by tumor-associated macrophages confers chemoresistance in peritoneally disseminated pancreatic cancer.
    Kuwada K; Kagawa S; Yoshida R; Sakamoto S; Ito A; Watanabe M; Ieda T; Kuroda S; Kikuchi S; Tazawa H; Fujiwara T
    J Exp Clin Cancer Res; 2018 Dec; 37(1):307. PubMed ID: 30537992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SNX6 predicts poor prognosis and contributes to the metastasis of pancreatic cancer cells via activating epithelial-mesenchymal transition.
    Hu P; Liang Y; Hu Q; Wang H; Cai Z; He J; Cai J; Liu M; Qin Y; Yu X; Jiang C; Zhang B; Wang W
    Acta Biochim Biophys Sin (Shanghai); 2018 Nov; 50(11):1075-1084. PubMed ID: 30307473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway.
    Zhang L; Wang D; Li Y; Liu Y; Xie X; Wu Y; Zhou Y; Ren J; Zhang J; Zhu H; Su Z
    PLoS One; 2016; 11(8):e0158529. PubMed ID: 27505247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer.
    Rumman M; Jung KH; Fang Z; Yan HH; Son MK; Kim SJ; Kim J; Park JH; Lim JH; Hong S; Hong SS
    Oncotarget; 2016 Nov; 7(47):78029-78047. PubMed ID: 27793006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.